Impairment of drug metabolism by disulfiram in man.
D000328:Adult; D000983:Antipyrine / Q000097:blood / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004221:Disulfiram / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D006207:Half-Life; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000652:urine*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000096:biosynthesis; D010648:Phenylacetates / Q000652:urine*; D010672:Phenytoin / Q000633:toxicity; D014642:Vanilmandelic Acid / Q000652:urine
D008333:Mandelic Acids; D010648:Phenylacetates; D014642:Vanilmandelic Acid; D010672:Phenytoin; D006899:Mixed Function Oxygenases; D000983:Antipyrine; D004221:Disulfiram; D004298:Dopamine; D009638:Norepinephrine